The eIg technology to generate Ig-like bispecific antibodies
Bispecific antibodies have emerged as therapeutic molecules with a multitude of modes of action and applications. Here, we present a novel approach to solve the light-chain problem for the generation of bispecific Ig-like antibodies using the second constant domain of IgE (EHD2) genetically modified...
Saved in:
Main Authors: | Lennart Kühl (Author), Nadine Aschmoneit (Author), Roland E. Kontermann (Author), Oliver Seifert (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
eIg-based bispecific T-cell engagers targeting EGFR: Format matters
by: Lennart Kühl, et al.
Published: (2023) -
A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3
by: Alexander Rau, et al.
Published: (2021) -
IgG-like Bispecific Antibody CD3×EpCAM Generated by Split Intein Against Colorectal Cancer
by: Lei Wang, et al.
Published: (2022) -
Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?
by: Jingjing Zhang, et al.
Published: (2022) -
Generation of robust bispecific antibodies through fusion of single-domain antibodies on IgG scaffolds: a comprehensive comparison of formats
by: Andreas V. Madsen, et al.
Published: (2023)